Healthcare Spending - A Focus Of Government Cost Containment

BMI View: Deficits remain a key challenge for the majority of governments across Europe. While many industries may see only limited downside risks from the situation, the pharmaceuticals & healthcare sector is facing considerable pressures as the structure of pharmaceutical payments in Europe makes the industry more vulnerable to fiscal austerity measures than elsewhere and as healthcare spending makes up a large proportion of government expenditure. As predicted by BMI, the dire fiscal situations facing many of these countries have necessitated a major acceleration in the introduction of harsher price erosion mechanisms across on pharmaceuticals in Europe. Furthermore, the

To read the full article, please choose one of the following options: